EU Industry Welcomes Generics Exemption From US Tariffs

Rules For Biosimilars Unclear As 15% Tariff Is Applied To Innovative Pharmaceuticals

 
• By Dave Wallace
  
The latest EU-US tariff agreement exempts generic medicines (Shutterstock)

More from Regulation

More from Policy & Regulation